(Press-News.org) (WASHINGTON, May 7, 2012) – A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients with chronic ITP treated with rituxamab.
Approximately 200,000 Americans suffer from ITP, a bleeding disorder in which the immune system destroys blood cells called platelets that are necessary for normal blood clotting, which can result in excessive bleeding and heavy bruising.1 Common treatment options for increasing platelet counts in the majority of patients with ITP include corticosteroid drug therapy, used to suppress a patient's immune system in order to help bring platelet counts back to normal; splenectomy, the surgical removal of the spleen, to halt the destruction of antibody-coated platelets found in the organ; and newer thrombopoietin (TPO)-mimetic agents to help stimulate platelet production. While these treatments are successful in many patients, all are associated with side effects: corticosteroids are associated with bone loss, cataracts, and other serious toxicity with long-term use; splenectomy can increase a patient's risk of infection; and TPO-mimetic agents can result in blood clots, and their long-term response in patients is not well-studied. In addition to their reported side effects, some patients with ITP stop responding or have insufficient response to these therapies.
More than ten years ago, researchers identified rituximab as an alternative treatment for patients with chronic ITP who have failed at least one other therapy. Rituximab specifically destroys B-cells – the cells responsible for producing antibodies that coat platelets and lead to their destruction – with low toxicity and decreased risk of infection compared to other treatments. Previous studies have shown that rituximab treatment resulted in normalized platelet counts lasting longer than one year in some patients with chronic ITP. Despite these encouraging reports, long-term data were previously lacking, and the durability and long-term safety of this treatment were largely unknown.
"While rituximab therapy for chronic ITP has been an exciting development, until now, due to a lack of sufficient patient numbers and follow-up in previous studies, we have only known how this treatment will affect ITP patients in the short term," said Vivek L. Patel, PhD, the study's first author and Research Associate at Weill Cornell Medical College in New York. "By utilizing the longest follow-up and the largest number of responders to the drug, our study sought to determine how children and adults with chronic ITP treated with rituximab would fare three, four, and five years down the road."
In this follow-up study, Dr. Patel's team reviewed 18 published clinical trials assessing rituximab treatment in children and adults with ITP and calculated initial and one-year response rates for 138 patients treated in 2000-2007 from seven clinical centers in the United States and Europe. Seventy-two adults with ongoing response one year from first treatment and 66 children with partial or complete response of any duration were included in the long-term analysis. The investigators calculated five-year response rates of 26 percent for children and 21 percent for adults. The researchers also analyzed the relationship of other clinical variables in response to rituximab and found no difference in projected five-year outcomes in children and adults who had undergone prior splenectomy versus those who had not. Age, gender, prior ITP duration, and response to other ITP treatment were also not predictive of duration of response.
Results are particularly encouraging for ITP patients and their physicians who now have more substantial long-term data to help them decide whether and when to treat with rituximab. "The results from this study provide clinicians and patients with accurate and realistic expectations of the long-term effect of rituximab and its potential to become a first-line treatment for ITP," said James B. Bussel, MD, senior author and Professor of Pediatrics at Weill Cornell Medical College. "Our next step is to try to augment the effect of rituximab by combining it with dexamethasone, a common steroid therapy for ITP, in order to determine its effect in conjunction with known treatment strategies."
###1About ITP. Platelet Disorder Support Association. http://www.pdsa.org/media-center/press-kit/about-itp.html. Accessed April 30, 2012.
The American Society of Hematology is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
SEATTLE – A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo. The vaccine used in the study did not contain the HIV virus, but it did contain HIV genes which were delivered to cells using a vector that employed a type of cold virus known as adenovirus serotype 5 (Ad5).
Of the 1,836 men examined in this study, 172 became infected with HIV. ...
Verygoodservice.com , the website dedicated to companies offering good products and good customer service, announces the inclusion of Teachers Building Society on its website.
The Dorset-based building society historically had a strong affinity with people who work in education, providing them with mortgages and savings products. It now offers its mortgages to Dorset residents too and the full range of savings products is available to the general public. Being a mutual, the building society is managed for the benefit of its members and has strong customer focus. This dedication ...
This press release is available in German.
With a range of diseases, doctors need unique features which they can use to unequivocally identify a patient's illness for an appropriate diagnosis. Scientists therefore search for the biomarkers for an illness or a combination of biomarkers, known as biosignatures, which are as easy as possible to measure. Researchers at the Max Planck Institute for Infection Biology in Berlin have now created complete gene and microRNA expression profiles together with important inflammatory mediators in the blood of tuberculosis and sarcoidosis ...
EUROMONITOR INTERNATIONAL REVEALS ENCOURAGING OUTLOOK
Key figures indicate that the Middle East region will remain a high focus area for global beauty majors, as demand continues to grow at a considerable rate. This was revealed by Epoc Messe Frankfurt at a press conference held to announce the upcoming Beautyworld Middle East, which will run from May 29th to 31st at the Dubai International Convention and Exhibition Centre.
Trends revealed by Euromonitor International, Knowledge Partner for Beautyworld Middle East and leading independent global strategic intelligence ...
One of Devon's most historic houses Great Fulford is a Domesday manor. The present house was mainly constructed in the early 16th century and is a semi fortified mansion built round a courtyard. It boasts a superb paneled Great Hall as well as a marvelous 17th century Great Staircase and other interesting 17th and 18th century rooms,
Great Fulford has been the home of the Fulford family since the reign of Richard 1 granted to William de Fulford. The manor originally belonged to the Priory of Canonsleigh until the Reformation when it was purchased by Sir John Fulford. ...
EAST LANSING, Mich. — For the first time, scientists have created a satellite-guided plan to effectively control the tsetse fly – an African killer that spreads "sleeping sickness" disease among humans and animals and wipes out $4.5 billion in livestock every year.
Michigan State University researchers developed the plan using a decade's worth of NASA satellite images of Kenyan landscape and by monitoring tsetse movement. With unprecedented precision, the plan can tell where and when to direct eradication efforts.
Current control efforts in Kenya are ineffective and ...
Cold Spring Harbor, NY – Scientists at Cold Spring Harbor Laboratory (CSHL) and Memorial Sloan-Kettering Cancer Center have amassed strong experimental evidence implying that commonly occurring large chromosomal deletions that are seen in many cancer types contain areas harboring multiple functionally linked genes whose loss, they posit, confers a survival advantage on growing tumors.
Looking closely at one large deletion -- a so-called copy-number alteration or CNA on 8p, the short arm of chromosome 8 -- in mouse models of human liver cancer, the team validated the ...
Slotland.com's new Greatest Hits slots game is a retro-style tribute to the music industry. It's a beautiful five reel, 19 payline no download slots game with a bonus game where players can top the charts with their gold and platinum records - and multiply their winnings up to five times.
The hit record "Disc" symbol is the Scatter and three Discs trigger the unique bonus game where wannabe music moguls release a new album and sell as many records as possible before the album loses its "Hype". When an album tops the charts or goes on tour Hype increases ...
The exploding stars known as Type Ia supernovae serve an important role in measuring the universe, and were used to discover the existence of dark energy. They're bright enough to see across large distances, and similar enough to act as a "standard candle" - an object of known luminosity. The 2011 Nobel Prize in Physics was awarded for the discovery of the accelerating universe using Type Ia supernovae. However, an embarrassing fact is that astronomers still don't know what star systems make Type Ia supernovae.
Two very different models explain the possible origin of ...
AURORA, Colo. (May 7, 2012) – New research from the University of Colorado School of Medicine shows that school-based health centers are highly effective in delivering comprehensive care, especially vaccines to adolescents.
The study, published today in the journal Pediatrics, highlights the value of a `captive audience' in a school setting where students can be easily reminded to get recommended vaccinations.
"School-based health centers can provide comprehensive care to children and adolescents who are hard to reach," said CU School of Medicine professor of pediatrics ...
